Skip to content
Daily cardiology cover art

All Episodes

Daily cardiology — 704 episodes · page 1 of 8

#
Title
1

ESC 2026: Evaluation of perfusion strategies in older patients

2

Beyond the Guidelines: Peripheral Artery Disease

3

ESC 2026: Immediate ambulatory ECG monitoring vs standard care in unexplained syncope

4

ESC 2026: Pulmonary vein isolation vs sham in AF

5

ESC 2026: Long-term blood pressure control and dementia risk

6

ESC 2026: Pacibekitug (IL-6 ligand mAb) in patients with CKD and high CV risk

7

ESC 2026: Response-tailored duration of antibiotic treatment for infectious endocarditis

8

ESC 2026: Implementation of SGLT2 inhibitors in patients with HF through a digital strategy

9

ESC 2026: Milvexian after recent ACS

10

ESC 2026: Plozasiran in severe hypertriglyceridaemia

11

Team-based collaborative care model in HF

12

Efficacy and safety of eplontersen in patients with transthyretin amyloid cardiomyopathy (ATTR-CM)

13

Anticoagulation for Atrial Fibrillation with Intermediate Stroke Risk

14

Statins for Reducing Events in the Elderly

15

Aficamten for Symptomatic non-obstructive Hypertrophic Cardiomyopathy

16

Coronary Angiography After Resuscitated ОНСА Without ST-elevation

17

CMR-guided management of mild-moderate left ventricular systolic dysfunction with an ICD

18

Case Discussion 128

19

H&H Academy in 7 minutes, Episode 11

20

Impact 54

21

Case Discussion 127

22

H&H Academy in 7 minutes, Episode 10

23

Low versus high dose strategies of intravenous nitroglycerin for the management of sympathetic crash

24

H&H Academy in 7 minutes, Episode 9

25

Case Discussion 126: Atrial flutter management

26

Case-Based Approach to Preventive Cardiology: Insight to Impact

27

H&H Academy in 7 minutes, Episode 8

28

An overview of the ESC 2025 Consensus on Mental Heath and Cardiovascular Disease

29

A brief summary of the NEO-MINDSET trial and the HI-PRO trial

30

A rapid rundown on REBOOT/BETAMI/DANBLOCK/ CAPITAL-RCT Meta-Analysis and the AQUATIC Trial

31

An overview of the ESC 2025 Guideline on Cardiovascular Disease and Pregnancy

32

Screening for Heart Failure in Patients with Diabetes Mellitus

33

The Role of Natriuretic Peptides in Preoperative Cardiovascular Evaluation Before Non-cardiac Surger

34

Precision Cardiovascular Medicine Through Biomarkers

35

The Role of NT-proBNP in Early Detection and Risk Stratification

36

2024 AHA/ACC Guideline on the Management of Lower Extremity Peripheral Artery Disease

37

Mastering the 2025 ACC/AHA hypertension guideline

38

Aspirin in Patients with Chronic Coronary Syndrome Receiving Oral Anticoagulation

39

Young Cardiologist Award 1404

40

Daily Cardiology Symposium 1404: Acute Coronary Syndromes

41

Daily Cardiology Symposium 1404: Perioperative Cardiovascular Management

42

Daily Cardiology Symposium 1404: Hypertension

43

Daily Cardiology Symposium 1404: Heart Failure

44

Daily Cardiology Symposium 1404: Peripheral Artery Disease

45

Daily Cardiology Symposium 1404: Diabetes Mellitus

46

Daily Cardiology Symposium 1404: Atrial Fibrillation

47

Daily Cardiology Symposium 1404: Chronic Coronary Syndrome

48

Daily Cardiology Symposium 1404: Welcome Remarks

49

Implantable Cardiac Defibrillators in Patients With Severe LV Systolic Dysfunction

50

Dapagliflozin in Patients Hospitalized for Heart Failure

51

Helicobacter pylori Screening After Acute Myocardial Infarction

52

Home-Based Care for Hypertension in Rural South Africa

53

Outcomes of cardiovascular screening in men aged 60–64 years

54

Mavacamten in Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

55

Impact of Drug-Coated Devices in Patients With Peripheral Arterial Disease

56

High-Dose Influenza Vaccine to Reduce Hospitalizations

57

Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension

58

Long-Term Anticoagulation Discontinuation After Catheter Ablation for Atrial Fibrillation

59

Temporal modulation of antiplatelet therapy in high-risk patients undergoing complex percutaneous co

60

Increasing the Potassium Level in Patients at High Risk for Ventricular Arrhythmias

61

Computed Tomography Angiography or Standard Care After Left Main PCI?

62

ESC 2025: β-blockers after myocardial infarction with mildly reduced ejection fraction

63

ESC 2025: SMuRF-less but inflamed

64

ESC 2025: Digitoxin in Patients with Heart Failure and Reduced Ejection Fraction

65

ESC 2025: Aficamten or Metoprolol Monotherapy for Obstructive Hypertrophic Cardiomyopathy

66

ESC 2025: Immediate versus staged complete revascularisation during index admission in patients

67

ESC 2025: Remote Screening for Asymptomatic Atrial Fibrillation

68

ESC 2025: Effect of evolocumab on saphenous vein graft patency after coronary artery bypass surgery

69

ESC 2025: Ticagrelor and Aspirin or Aspirin Alone after Coronary Surgery for Acute Coronary Syndrome

70

ESC 2025: Vericiguat for patients with heart failure and reduced ejection fraction across the risk s

71

ESC 2025: Reduction of Antihypertensive Treatment in Nursing Home Residents

72

ESC 2025: High-Dose Influenza Vaccine Effectiveness against Hospitalization in Older Adults

73

ESC 2025: B. Aminian, MD

74

Apixaban for Extended Treatment of Provoked Venous Thromboembolism (HI-PRO)

75

Impact 52: FINEARTS-HF: Modes of Death in HFmrEF & HFpEF

76

Impact 51: Thrombolysis after recent DOAC intake

77

H&H Academy in 7 minutes, Episode 7

78

Impact 50: Thrombolysis before thrombectomy: A bridge not fallen

79

Case Discussion 125: DVT Prophylaxis in Post-Ischemic Stroke Patients

80

Impact 49: SGLT2 inhibitors in CKD: are they really effective in all patients?

81

Impact 48: DOACs for Rheumatic Heart Disease-Associated AF Post-Bioprosthetic MVR

82

Case Discussion 124: Anticoagulation in Patients with Mitral Stenosis

83

23rd ACC 2025 Congress Coverage: FAME 3 Trial

84

22nd ACC 2025 Congress Coverage: FLAVOUR II Trial

85

21st ACC 2025 Congress Coverage: DapaTavi Trial

86

20th ACC 2025 Congress Coverage: ALLEPRE Trial

87

19th ACC 2025 Congress Coverage: HPV Infection and Cardiovascular Disease

88

18th ACC 2025 Congress Coverage: SOUL Trial

89

L H&H Accademy in 7 Minutes, Ep 6, 50y M

90

17th ACC 2025 Congress Coverage: ALPACA Trial

91

16th ACC 2025 Congress Coverage: MI and Cardiovascular Risks Associated with Cannabis Use

92

15th ACC 2025 Congress Coverage: DapaTAVI Trial

93

14th ACC 2025 Congress Coverage: SBP < 130 mmHg Linked to Reduced CV Mortality in Adults +80 Y

94

13th ACC 2025 Congress Coverage: EquiOx Study

95

12th ACC 2025 Congress Coverage: RIVAWAR Trial

96

11th ACC 2025 Congress Coverage: HOST-BR Trial

97

10th ACC 2025 Congress Coverage: FAIR-HF2 Trial

98

9th ACC 2025 Congress Coverage: ALIGN-AR Trial

99

8th ACC 2025 Congress Coverage: BHF PROTECT-TAVI Trial

100

7th ACC 2025 Congress Coverage: WARRIOR Trial